+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Electrophoresis Equipment Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 350 Pages
  • July 2025
  • Region: Global
  • Expert Market Research
  • ID: 6163206
The global electrophoresis equipment market size was valued at USD 3.20 Billion in 2024, driven by intensive research and development activities across the globe. The market is expected to grow at a CAGR of 5.70% during the forecast period of 2025-2034, with the values likely to rise from USD 3.38 Billion in 2025 to USD 5.57 Billion by 2034.

Global Electrophoresis Equipment Market Overview

Electrophoresis equipment facilitates the migration of molecules toward oppositely charged electrodes. Gel electrophoresis is widely used in laboratories to separate DNA, RNA, or protein molecules on the basis of their size or electric charge. The increased application of this laboratory method in genomic and proteomic research activities is significantly driving the electrophoresis equipment market demand.

The rise in the launch of innovative products by the leading pharmaceutical companies is poised to boost market growth. In February 2024, Invitrogen, a brand operated by Thermo Fisher Scientific, revealed its fully integrated E-Gel™ Power Snap Plus Electrophoresis System. With the capability to run, visualize, and image DNA samples in a single platform, this device can handle 96 samples per run. The electrophoresis system offers high-resolution images and a user-friendly interface with preset protocols, real-time visualization, and easy analysis of routine DNA examinations, among others. The development of such integrated platforms will enhance efficiency in research and biotechnology applications. Consequently, this will propel the electrophoresis equipment market growth.

The market is further driven by the increasing research funding and rising investment by the biotechnology and pharmaceutical companies to address the growing demand for technologically advanced electrophoresis equipment. In addition, the increased focus on personalized therapeutics is poised to influence the market size of electrophoresis equipment positively.

Global Electrophoresis Equipment Market Segmentation

Electrophoresis Equipment Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Products

  • Electrophoresis Reagents
  • Electrophoresis Systems
  • Gel Documentation Systems
  • Electrophoresis Software

Market Breakup by Application

  • Diagnostic Application
  • Research Application
  • Quality Control & Process Validation

Market Breakup by End User

  • Hospital & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Electrophoresis Equipment Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Thermo Fisher Scientific
  • Bio-RAD Laboratories
  • Merck Group
  • Agilent Technologies
  • Danaher Corporation
  • QIAGEN
  • Harvard Apparatus
  • Lonza Group Ltd.
  • Perkin Elmer
  • Shimadzu Corporation
  • Biocompare
  • Thistle Scientific
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Queries Solved in the Global Electrophoresis Equipment Market Report

  • How will the market landscape evolve in the coming years?
  • What are the major market trends influencing the market?
  • What are the major drivers, opportunities, and restraints in the market?
  • What will be the effect of each driver, challenge, and opportunity on the market?
  • Which country is poised to lead the market share in the forecast period?
  • Which country is expected to experience expedited growth during the forecast period?
  • What type of products are available in the market?
  • What are the latest product launches in the market?
  • What type of technologies are being applied to the novel products?
  • What type of electrophoresis systems are expected to dominate the respective market segment?
  • What application areas are expected to significantly impact the growth of the market?
  • Who are the key players of the market?
  • What are the key research initiatives expected to boost the electrophoresis equipment market value during the forecast period?
  • What are the most impactful partnerships, collaborations, and mergers & acquisitions shaping the market dynamics of the electrophoresis equipment?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Electrophoresis Equipment Market Overview
3.1 Global Electrophoresis Equipment Market Historical Value (2018-2024)
3.2 Global Electrophoresis Equipment Market Forecast Value (2025-2034)
4 Global Electrophoresis Equipment Market Landscape*
4.1 Global Cardiac Pacemaker: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cardiac Pacemaker: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
4.2.3 Analysis by End User
5 Global Electrophoresis Equipment Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Electrophoresis Equipment Market Segmentation (2018-2034)
6.1 Global Electrophoresis Equipment Market (2018-2034) by Products
6.1.1 Market Overview
6.1.2 Electrophoresis Reagents
6.1.3 Electrophoresis Systems
6.1.4 Gel Documentation Systems
6.1.5 Electrophoresis Software
6.2 Global Electrophoresis Equipment Market (2018-2034) by Application
6.2.1 Market Overview
6.2.2 Diagnostic Application
6.2.3 Research Application
6.2.4 Quality Control & Process Validation
6.3 Global Electrophoresis Equipment Market (2018-2034) by End User
6.3.1 Market Overview
6.3.2 Hospital & Diagnostic Centers
6.3.3 Pharmaceutical & Biotechnology Companies
6.3.4 Academic & Research Institutes
6.3.5 Others
6.4 Global Electrophoresis Equipment Market (2018-2034) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Cardiac Pacemaker Market (2018-2034)
7.1 North America Cardiac Pacemaker Market (2018-2034) by Products
7.1.1 Market Overview
7.1.2 Electrophoresis Reagents
7.1.3 Electrophoresis Systems
7.1.4 Gel Documentation Systems
7.1.5 Electrophoresis Software
7.2 North America Cardiac Pacemaker Market (2018-2034) by Application
7.2.1 Market Overview
7.2.2 Diagnostic Application
7.2.3 Research Application
7.2.4 Quality Control & Process Validation
7.3 North America Cardiac Pacemaker Market (2018-2034) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Cardiac Pacemaker Market (2018-2034)
8.1 Europe Cardiac Pacemaker Market (2018-2034) by Products
8.1.1 Market Overview
8.1.2 Electrophoresis Reagents
8.1.3 Electrophoresis Systems
8.1.4 Gel Documentation Systems
8.1.5 Electrophoresis Software
8.2 Europe Cardiac Pacemaker Market (2018-2034) by Applications
8.2.1 Market Overview
8.2.2 Diagnostic Application
8.2.3 Research Application
8.2.4 Quality Control & Process Validation
8.3 Europe Cardiac Pacemaker Market (2018-2034) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Quality Control & Process Validation
9 Asia Pacific Cardiac Pacemaker Market (2018-2034)
9.1 Asia Pacific Cardiac Pacemaker Market (2018-2034) by Products
9.1.1 Market Overview
9.1.2 Electrophoresis Reagents
9.1.3 Electrophoresis Systems
9.1.4 Gel Documentation Systems
9.1.5 Electrophoresis Software
9.2 Asia Pacific Cardiac Pacemaker Market (2018-2034) by Application
9.2.1 Market Overview
9.2.2 Diagnostic Application
9.2.3 Research Application
9.2.4 Quality Control & Process Validation
9.3 Asia Pacific Cardiac Pacemaker Market (2018-2034) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Quality Control & Process Validation
10 Latin America Cardiac Pacemaker Market (2018-2034)
10.1 Latin America Cardiac Pacemaker Market (2018-2034) by Products
10.1.1 Market Overview
10.1.2 Electrophoresis Reagents
10.1.3 Electrophoresis Systems
10.1.4 Gel Documentation Systems
10.1.5 Electrophoresis Software
10.2 Latin America Cardiac Pacemaker Market (2018-2034) by Applications
10.2.1 Market Overview
10.2.2 Diagnostic Application
10.2.3 Research Application
10.2.4 Quality Control & Process Validation
10.3 Latin America Cardiac Pacemaker Market (2018-2034) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Quality Control & Process Validation
11 Middle East and Africa Cardiac Pacemaker Market (2018-2034)
11.1 Middle East and Africa Cardiac Pacemaker Market (2018-2034) by Products
11.1.1 Market Overview
11.1.2 Electrophoresis Reagents
11.1.3 Electrophoresis Systems
11.1.4 Gel Documentation Systems
11.1.5 Electrophoresis Software
11.2 Middle East and Africa Cardiac Pacemaker Market (2018-2034) by Application
11.2.1 Market Overview
11.2.2 Diagnostic Application
11.2.3 Research Application
11.2.4 Quality Control & Process Validation
11.3 Middle East and Africa Cardiac Pacemaker Market (2018-2034) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Quality Control & Process Validation
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Quality Control & Process Validation
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Thermo Fisher Scientific
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Bio-RAD Laboratories
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Merck Group
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Agilent Technologies
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Danaher Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 QIAGEN
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Harvard Apparatus
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Lonza Group Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Perkin Elmer
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Shimadzu Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Biocompare
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Thistle Scientific
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications

Companies Mentioned

  • Thermo Fisher Scientific
  • Bio-RAD Laboratories
  • Merck Group
  • Agilent Technologies
  • Danaher Corporation
  • QIAGEN
  • Harvard Apparatus
  • Lonza Group Ltd.
  • Perkin Elmer
  • Shimadzu Corporation
  • Biocompare
  • Thistle Scientific